rediff.com
X   
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570

532296 GLENMARK Group (A)

Glenmark Pharmaceuticals Ltd. LIVE on BSE (View NSE)   

Add to watchlist
 
563.00   -10.75   -1.87%
Volume 30,998
Prev close 573.75
Day's H/L (Rs.) 578.45 - 556.65
52wk H/L (Rs.) 607.70 - 342.50
Mkt Cap (Rs. Cr) 15,251.67
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

GLENMARK

Glenmark Pharmaceuticals Ltd. LIVE on NSE (View BSE)   

Add to watchlist
 
564.65   -9.00   -1.57%
Volume 1,305,781
Prev close 573.65
Day's H/L (Rs.) 578.40 - 557.20
52wk H/L (Rs.) 609.00 - 341.70
Turnover (Rs. Cr) 74.39
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Realtime news for Glenmark Pharmaceuticals Ltd. (See all 811 news)

22 May 2013, 17:46
MSD-Glenmark case to provide clarity on multiple patenting - 16 hour(s) ago
Glenmark Generics receives ANDA from US FDA - 5 day(s) ago
Glenmark gets USFDA nod for headache drug - 15 May 2013
Glenmark Pharma hits 52-week high - 6 day(s) ago
Glenmark CMD: New pricing policy will spell doom for pharma firms - 2 day(s) ago

Market Voices for Glenmark Pharmaceuticals Ltd.  (See all 66 market voices)   

140 Characters
  Cancel
Expert Voices - 14 May 2013
#Glenmark-Pharmaceuticals-Ltd
is a good stock within the pharma sector, says Deven Choksey of KR Choksey Securities. (ET Now)
#money
Reply   |   Share
Siya - 1 day(s) ago whats todays news in this stock...crossed 600...great..?
#Glenmark-Pharmaceuticals-Ltd
Reply   |   Share
dharmendra kothari - 1 day ago  kindly get me news
Reply   |  Share

BSE Announcements from Glenmark Pharmaceuticals Ltd. (See all)

Glenmark Generics receives final ANDA approvals for Zolmitriptan Tablest, 2.5 and 5 mg and Zolmitriptan Orally Disintegrating Tablest, 2.5 and 5 mg - 15 May 2013
Outcome of Board Meeting - 09 May 2013

Company details for Glenmark Pharmaceuticals Ltd.

Report Card

PE Ratios
40.22
EPS (Rs.)
14.26
Sales (Rs. Cr)
485.21
Face Value (Rs.)
1
Net Profit
Margin (%)
 
15.83
Last Bonus
1:1
Last Dividend(%)
200
Return on
Average Equity
 
12.13

Research Centre

Results: Quarterly  |  Half Yearly  |  Annual
Statements: Balance Sheet  |  P&L  |  Cash Flow  More: Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

Glenmark Pharmaceuticals Ltd. performance snapshot

If you had invested Rs.  in Glenmark Pharmaceuticals Ltd.,   ago

You would have  Rs. 000.00 

Add to portfolio

Compare Glenmark Pharmaceuticals Ltd. with other stocks

GlaxoSmithKline Pharmaceuticals Ltd.
2,321.15
Dr. Reddy's Laboratories Ltd.
2,077.65
Show more companies
GlaxoSmithKline Pharmaceuticals Ltd.
2,321.15
Dr. Reddy's Laboratories Ltd.
2,077.65
Biocon Ltd.
285.40
Divi's Laboratories Ltd.
1,121.15
Lupin Ltd.
804.25
Aurobindo Pharma Ltd.
192.25
Cadila Healthcare Ltd.
818.45
Sun Pharmaceutical Industries Ltd.
965.30
Wockhardt Ltd.
1,798.30
Ipca Laboratories Ltd.
584.70
Show less companies
Close
Add Glenmark Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Glenmark Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close